Drug: Fentora
2006 sales: $370 million
Manufacturer: Cephalon
Safety concern: Warning; improper dosing leading to death
Related Articles:
> New warning for off-label Fentora. Report [1]
> Red flags raised on Fentora misuse. Report [2]
> FDA approves Fentora for cancer pain. Report [3]
> Cephalon shares jump on Fentora decision. Report [4]
> Cephalon takes heat for off-label narcotic promotion. Report [5]
Links:
[1] http://www.fiercepharma.com/story/new-warning-label-fentora/2007-09-27
[2] http://www.fiercepharma.com/story/red-flags-raised-fentora-misuse/2007-09-14
[3] http://www.fiercebiotech.com/story/fda-approves-fentora-for-cancer-pain/2006-09-26?utm_source=related&utm_medium=internal
[4] http://www.fiercebiotech.com/story/cephalon-shares-jump-on-fentora-decision/2006-06-30?utm_source=related&utm_medium=internal
[5] http://www.fiercebiotech.com/story/cephalon-takes-heat-for-off-label-narcotic-promotion/2006-11-21
[6] http://www.fiercepharma.com/special-reports/9-xolair-top-10-warnings-and-recalls
[7] http://www.fiercepharma.com/special-reports/top-10-drug-warnings-and-recalls-2007